Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older

BACKGROUND AND AIM: Elderly patients with hepatitis C virus (HCV) infection have worse interferon‐based treatment outcomes than young patients. Direct‐acting antiviral (DAA) regimens have enabled the treatment of previously difficult‐to‐cure populations. There are few studies that specifically asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Parmar, Parmvir, Shafran, Stephen D, Borgia, Sergio M, Doucette, Karen, Cooper, Curtis L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857276/
https://www.ncbi.nlm.nih.gov/pubmed/33553664
http://dx.doi.org/10.1002/jgh3.12480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857276/
https://www.ncbi.nlm.nih.gov/pubmed/33553664
http://dx.doi.org/10.1002/jgh3.12480

Ejemplares similares